Mescaline and phencyclidine (PCP) are potent hallucinogenic agents affecting human and animal behavior. As their psychotropic effects remain poorly understood, further research is necessary to characterize phenotypes they evoke in various animal models. Zebrafish (Danio rerio) are rapidly emerging as a new model organism for neuroscience research. Here, we examine the effects of mescaline (5-20 mg/l) and PCP (0.5-3 mg/l) in several zebrafish paradigms, including the novel tank, open field and shoaling tests. Mescaline and PCP dose-dependently increased top activity in the novel tank test, also reducing immobility and disrupting the patterning of zebrafish swimming, as assessed by ethograms. PCP, but not mescaline, evoked circling behavior in the open field test. At the highest doses tested, mescaline markedly increased, while PCP did not affect, zebrafish shoaling behavior. Finally, 20 mg/l mescaline did not alter, and 3 mg/l PCP elevated, whole-body cortisol levels. Overall, our studies indicate high sensitivity of zebrafish models to hallucinogenic compounds with complex behavioral and physiological effects.
Introduction
Mescaline (3,4,5-trimethoxyphenethylamine) is one of the oldest hallucinogens known to man (Kapadia and Fayez, 1970) . Produced naturally in the peyote cacti, this phenethylamine agent acts primarily on the serotonergic 5HT 1A/2A/B/C receptors (Glennon et al., 1984; Halberstadt et al., 2009; Monte et al., 1997; Palenicek et al., 2008; Shannon et al., 1984) , also showing dopaminergic activity (Trulson et al., 1983) . The clinical effects of mescaline, similar to the psychedelic action of lysergic acid diethylamide (LSD) and 3,4-methylenedioxymethamphetamine (MDMA), include euphoria, hallucinations, depersonalization and psychoses (Gouzoulis-Mayfrank et al., 1998; Hermle et al., 1992; Schwarz et al., 1956; Wolbach et al., 1962) . In rodent models, mescaline modulates locomotion, exploration, cognitive function (Geyer et al., 1979; Koupilova et al., 1999; Palenicek et al., 2008; Sykes, 1986) , aggression, startle (Palenicek et al., 2008; Sbordone and Carder, 1974; Sbordone et al., 1979) and motor responses (Canal et al., 2010; Silva and Calil, 1975; Yamamoto et al., 1992) .
Phencyclidine (PCP) is another potent hallucinogenic drug, representing a synthetic arylcyclohexylamine originally developed as an anesthetic (Bristow et al., 1993; Dimpfel and Spuler, 1990; Johnson and Jones, 1990) . Similar to ketamine, PCP acts as a glutamatergic N-methyl-D-aspartate (NMDA) antagonist (Bristow et al., 1993; Dimpfel and Spuler, 1990; Johnson and Jones, 1990) , also showing cholinergic (Haring and Kloog, 1984) and monoaminergic activity (Choi et al., 2009; Nagai et al., 2009; Pozzi et al., 2010; Seeman et al., 2009 ). In humans, PCP evokes analgesia, ataxia, euphoria, anxiety, hallucinations and psychoses (Gorelick and Wilkins, 1989; Gorelick et al., 1986 Gorelick et al., , 1989 Pearlson, 1981) . Rodent models demonstrate similar behavioral effects of PCP, including hyperlocomotion, stereotypies (Sturgeon et al., 1982) , context-specific alteration of anxiety (Turgeon et al., 2011) and learning/memory deficits (Willetts et al., 1990) .
Mounting evidence indicates the growing significance of hallucinogenic drugs in biopsychiatry research (Check, 2004; Friedman, 2006; Halpern, 1996; Sessa, 2008) . The resurgence of interest in psychedelic research requires new approaches and novel experimental models to study hallucinogenic drugs (Marona-Lewicka et al., 2011; Vollenweider and Kometer, 2010) . Complementing rodent models, aquatic species can be effectively used to study these compounds (Abramson et al., 1979; Braida et al., 2007; Gettner et al., 1965; Saxena et al., 1962; Webb and Farquharson, 1971) . Progress in Neuro-Psychopharmacology & Biological Psychiatry 37 (2012) 194-202 Abbreviations: ANOVA, analysis of variance; DMSO, dimethyl sulfoxide; ELISA, enzyme-linked immunosorbent assay; Fps, frames per second; HPI, Hypothalamicpituitary-interrenal; LSD, lysergic acid diethylamide; MDMA, 3,4-methylenedioxymethamphetamine; NMDA, N-methyl-D-aspartate; PBS, phosphate buffered saline; PCP, phencyclidine; SPSS, statistical package for the social sciences; 5HT, serotonin.
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